Verrica Pharmaceuticals(VRCA) - 2025 Q3 - Earnings Call Transcript

Verrica Pharmaceuticals (NasdaqGM:VRCA) Q3 2025 Earnings Call November 17, 2025 08:30 AM ET Company ParticipantsJayson Rieger - President and CEOStacy Ku - Biotechnology Equity ResearchKevin Gardner - Managing DirectorJohn Kirby - Interim CFOConference Call ParticipantsDennis Ding - VP and Equity Research AnalystNone - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals third quarter 2025 corporate update conference call. At this time, all participants ...